Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Efgartigimod alfa

Catalog No. T9901A-479 Copy Product Info
🥰Excellent
Efgartigimod alfa is an Fc receptor blocker used to treat myasthenia gravis. It reduces overall IgG levels, including the pathogenic acetylcholine receptor (AChR) antibodies found in myasthenia gravis. Additionally, it can be formulated with hyaluronidase.

Efgartigimod alfa

Copy Product Info
🥰Excellent
Catalog No. T9901A-479

Efgartigimod alfa is an Fc receptor blocker used to treat myasthenia gravis. It reduces overall IgG levels, including the pathogenic acetylcholine receptor (AChR) antibodies found in myasthenia gravis. Additionally, it can be formulated with hyaluronidase.

Efgartigimod alfa
Cas No. 1821402-21-4
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Efgartigimod alfa is an Fc receptor blocker used to treat myasthenia gravis. It reduces overall IgG levels, including the pathogenic acetylcholine receptor (AChR) antibodies found in myasthenia gravis. Additionally, it can be formulated with hyaluronidase.
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Chemical Properties
Cas No.1821402-21-4
Storage & Solubility Information
Storage-20°C for 1 year | Shipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Efgartigimod alfa | purchase Efgartigimod alfa | Efgartigimod alfa cost | order Efgartigimod alfa